ArticleArthritis research & therapy2023

Real-life drug retention rate and safety of rituximab when treating rheumatic diseases: a single-centre Swiss retrospective cohort study.

Alexandre Dumusc et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.